Immunomodulatory effects of radiotherapy

S Kumari, S Mukherjee, D Sinha, S Abdisalaam… - International journal of …, 2020 - mdpi.com
Radiation therapy (RT), an integral component of curative treatment for many malignancies,
can be administered via an increasing array of techniques. In this review, we summarize the …

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

RCE Hsieh, S Krishnan, RC Wu, AR Boda, A Liu… - Science …, 2022 - science.org
Radiotherapy (RT) of colorectal cancer (CRC) can prime adaptive immunity against tumor-
associated antigen (TAA)–expressing CRC cells systemically. However, abscopal tumor …

[HTML][HTML] Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma

SU Lee, TH Kim - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external
beam radiation therapy has emerged as a promising approach for managing HCC. Proton …

[HTML][HTML] Proton beam therapy for hepatocellular carcinoma: Multicenter prospective registry study in Japan

M Mizumoto, H Ogino, T Okumura, K Terashima… - International Journal of …, 2024 - Elsevier
Purpose A prospective multicenter registry study was started May 2016 in Japan to evaluate
the efficacy and safety of proton beam therapy (PBT) for hepatocellular carcinoma (HCC) …

Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis

JY Cheng, CM Liu, YM Wang, HC Hsu, EY Huang… - Radiation …, 2020 - Springer
Background Proton radiotherapy has a dosimetric advantage over photon radiotherapy.
Many retrospective studies have shown promising results with proton radiotherapy in …

Predictors of radiation-induced liver disease in eastern and western patients with hepatocellular carcinoma undergoing proton beam therapy

CE Hsieh, BP Venkatesulu, CH Lee, SP Hung… - International Journal of …, 2019 - Elsevier
Purpose To identify predictors of radiation-induced liver disease (RILD) in patients with
hepatocellular carcinoma (HCC) treated with proton beam therapy (PBT). Methods This …

[HTML][HTML] Intensity modulated proton therapy for hepatocellular carcinoma: initial clinical experience

RS Bhangoo, TC Mullikin, JB Ashman… - Advances in Radiation …, 2021 - Elsevier
Purpose Our purpose was to assess the safety and efficacy of intensity modulated proton
therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). Methods and Materials …

Dosimetric analysis and normal-tissue complication probability modeling of child-pugh score and albumin-bilirubin grade increase after hepatic irradiation

J Pursley, I El Naqa, NN Sanford, B Noe, JY Wo… - International Journal of …, 2020 - Elsevier
Purpose This study aimed to develop robust normal-tissue complication probability (NTCP)
models for patients with hepatocellular carcinoma treated with radiation therapy (RT) using …

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group

JS Parzen, W Hartsell, J Chang, S Apisarnthanarax… - Radiation …, 2020 - Springer
Background Recent advances in radiotherapy techniques have allowed ablative doses to be
safely delivered to inoperable liver tumors. In this setting, proton beam radiotherapy (PBT) …

[HTML][HTML] Proton beam therapy for liver cancers

M Chuong, A Kaiser, J Molitoris… - Journal of …, 2020 - ncbi.nlm.nih.gov
Proton beam therapy (PBT) delivers less dose to nearby normal organs compared to X-ray
therapy (XRT), which is particularly relevant for treating liver cancers given that both mean …